Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Liberty Latin America Ltd.LILA · Entity 4630 | MD, CHIEF ACCOUNTING OFFICER | June 16, 2026 | July 18, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Liberty Latin America Ltd.
Report date June 16, 2026 · Filed July 18, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Series A Preference SharesSEC Table I · non-derivative | Direct | 4,918 |
Reported balance
After 2026-06-16 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-06-16 · Other · Acquired 4,918 · Balance 4,918 F1: On May 21, 2026, the Issuer announced that an authorized committee of the Issuer's board of directors declared a special dividend on each of its outstanding common shares payable on June 16, 2026 to all holders of record as of 5:00 p.m., New York City time, on June 1, 2026 consisting of a special dividend of 0.10 shares of newly issued 9.0% Fixed Rate Cumulative Perpetual Redeemable Series A Preferred Shares (the "Preferred Shares"), having an initial liquidation price of $25 per Preferred Share (the "Dividend"). As a result of the Dividend, the reporting person directly received 4,918 Preferred Shares. |
| Series A Preference SharesSEC Table I · non-derivative | IndirectBy IRA | 140 |
Reported balance
After 2026-06-16 transaction · row 2
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 2 · 2026-06-16 · Other · Acquired 140 · Balance 140 F2: As a result of the Dividend, the reporting person directly received 140 Preferred Shares in his IRA account. |
| Restricted Share Units PSEC Table II · derivative / convertible security | Direct | 2,164 |
Reported balance
After 2026-06-17 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2026-06-17 · Other · Acquired 2,164 · Balance 2,164 F3: Each Restricted Share Unit P ("RSU") represents a right to receive one share of the Issuer's Series A Preference Shares at settlement. F4: The RSUs vest in full on March 15, 2027. |
| Share Appreciation Rights ASEC Table II · derivative / convertible security · Conversion / exercise price $13.03 · Expires 2028-05-01 | Direct | 15,170 |
Reported balance
Holding disclosure · report date 2026-06-16 · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · Balance 15,170 F5: The derivative security is fully vested. F6: This share appreciation right award ("SAR") was previously reported as a SAR relating to 10,609 shares of the Issuer's common stock at a base price of $18.63 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3. |
| Share Appreciation Rights ASEC Table II · derivative / convertible security · Conversion / exercise price $13.93 · Expires 2029-05-01 | Direct | 14,847 |
Reported balance
Holding disclosure · report date 2026-06-16 · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · Balance 14,847 F5: The derivative security is fully vested. F8: This SAR was previously reported as a SAR relating to 10,383 shares of the Issuer's common stock at a base price of $19.91 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3. |
| Share Appreciation Rights ASEC Table II · derivative / convertible security · Conversion / exercise price $7.29 · Expires 2030-03-16 | Direct | 26,709 |
Reported balance
Holding disclosure · report date 2026-06-16 · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · Balance 26,709 F5: The derivative security is fully vested. F10: This SAR was previously reported as a SAR relating to 18,678 shares of the Issuer's common stock at a base price of $10.42 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3. |
| Share Appreciation Rights ASEC Table II · derivative / convertible security · Conversion / exercise price $9.80 · Expires 2031-03-16 | Direct | 47,666 |
Reported balance
Holding disclosure · report date 2026-06-16 · row 10
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 10 · Balance 47,666 F5: The derivative security is fully vested. F12: This SAR was previously reported as a SAR relating to 33,333 shares of the Issuer's common stock at a base price of $14.00 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3. |
| Share Appreciation Rights ASEC Table II · derivative / convertible security · Conversion / exercise price $9.80 · Expires 2031-03-16 | Direct | 23,699 |
Reported balance
Holding disclosure · report date 2026-06-16 · row 12
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 12 · Balance 23,699 F5: The derivative security is fully vested. F14: This SAR was previously reported as a SAR relating to 16,573 shares of the Issuer's common stock at a base price of $14.00 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3. |
| Share Appreciation Rights ASEC Table II · derivative / convertible security · Conversion / exercise price $6.78 · Expires 2032-03-11 | Direct | 36,386 |
Reported balance
Holding disclosure · report date 2026-06-16 · row 14
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 14 · Balance 36,386 F5: The derivative security is fully vested. F16: This SAR was previously reported as a SAR relating to 25,445 shares of the Issuer's common stock at a base price of $9.69 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3. |
| Share Appreciation Rights ASEC Table II · derivative / convertible security · Conversion / exercise price $5.47 · Expires 2033-03-20 | Direct | 23,626 |
Reported balance
Holding disclosure · report date 2026-06-16 · row 16
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 16 · Balance 23,626 F5: The derivative security is fully vested. F18: This SAR was previously reported as a SAR relating to 16,522 shares of the Issuer's common stock at a base price of $7.81 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3. |
| Share Appreciation Rights ASEC Table II · derivative / convertible security · Conversion / exercise price $4.31 · Expires 2034-03-12 | Direct | 29,303 |
Reported balance
Holding disclosure · report date 2026-06-16 · row 18
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 18 · Balance 29,303 F20: The SARs vest in full on March 15 2027. F21: This SAR was previously reported as a SAR relating to 20,492 shares of the Issuer's common stock at a base price of $6.16 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3. |
| Share Appreciation Rights ASEC Table II · derivative / convertible security · Conversion / exercise price $4.68 · Expires 2035-03-14 | Direct | 27,082 |
Reported balance
Holding disclosure · report date 2026-06-16 · row 20
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 20 · Balance 27,082 F23: The SARs vest in two equal annual installments on March 15 of 2027 and 2028. F24: This SAR was previously reported as a SAR relating to 18,939 shares of the Issuer's common stock at a base price of $6.69 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3. |
| Share Appreciation Rights ASEC Table II · derivative / convertible security · Conversion / exercise price $5.31 · Expires 2036-03-13 | Direct | 23,978 |
Reported balance
Holding disclosure · report date 2026-06-16 · row 22
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 22 · Balance 23,978 F26: The Share Appreciation Rights vest in three equal annual installments on March 15 of 2027, 2028 and 2029. F27: This SAR was previously reported as a SAR relating to 16,768 shares of the Issuer's common stock at a base price of $7.58 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3. |
| Share Appreciation Rights CSEC Table II · derivative / convertible security · Conversion / exercise price $12.41 · Expires 2028-05-01 | Direct | 31,190 |
Reported balance
Holding disclosure · report date 2026-06-16 · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · Balance 31,190 F5: The derivative security is fully vested. F7: This SAR was previously reported as a SAR relating to 21,218 shares of the Issuer's common stock at a base price of $18.24 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3. |
| Share Appreciation Rights CSEC Table II · derivative / convertible security · Conversion / exercise price $13.63 · Expires 2029-05-01 | Direct | 30,526 |
Reported balance
Holding disclosure · report date 2026-06-16 · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · Balance 30,526 F5: The derivative security is fully vested. F9: This SAR was previously reported as a SAR relating to 20,766 shares of the Issuer's common stock at a base price of $20.03 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3. |
| Share Appreciation Rights CSEC Table II · derivative / convertible security · Conversion / exercise price $7.13 · Expires 2030-03-16 | Direct | 54,913 |
Reported balance
Holding disclosure · report date 2026-06-16 · row 9
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 9 · Balance 54,913 F5: The derivative security is fully vested. F11: This SAR was previously reported as a SAR relating to 37,356 shares of the Issuer's common stock at a base price of $10.48 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3. |
| Share Appreciation Rights CSEC Table II · derivative / convertible security · Conversion / exercise price $9.60 · Expires 2031-03-16 | Direct | 98,000 |
Reported balance
Holding disclosure · report date 2026-06-16 · row 11
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 11 · Balance 98,000 F5: The derivative security is fully vested. F13: This SAR was previously reported as a SAR relating to 66,667 shares of the Issuer's common stock at a base price of $14.10 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3. |
| Share Appreciation Rights CSEC Table II · derivative / convertible security · Conversion / exercise price $9.60 · Expires 2031-03-16 | Direct | 48,724 |
Reported balance
Holding disclosure · report date 2026-06-16 · row 13
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 13 · Balance 48,724 F5: The derivative security is fully vested. F15: This SAR was previously reported as a SAR relating to 33,146 shares of the Issuer's common stock at a base price of $14.10 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3. |
| Share Appreciation Rights CSEC Table II · derivative / convertible security · Conversion / exercise price $6.56 · Expires 2032-03-11 | Direct | 74,808 |
Reported balance
Holding disclosure · report date 2026-06-16 · row 15
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 15 · Balance 74,808 F5: The derivative security is fully vested. F17: This SAR was previously reported as a SAR relating to 50,890 shares of the Issuer's common stock at a base price of $9.63 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3. |
| Share Appreciation Rights CSEC Table II · derivative / convertible security · Conversion / exercise price $5.30 · Expires 2033-03-20 | Direct | 48,574 |
Reported balance
Holding disclosure · report date 2026-06-16 · row 17
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 17 · Balance 48,574 F5: The derivative security is fully vested. F19: This SAR was previously reported as a SAR relating to 33,044 shares of the Issuer's common stock at a base price of $7.78 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3. |
| Share Appreciation Rights CSEC Table II · derivative / convertible security · Conversion / exercise price $4.24 · Expires 2034-03-12 | Direct | 60,246 |
Reported balance
Holding disclosure · report date 2026-06-16 · row 19
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 19 · Balance 60,246 F20: The SARs vest in full on March 15 2027. F22: This SAR was previously reported as a SAR relating to 40,984 shares of the Issuer's common stock at a base price of $6.22 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3. |
| Share Appreciation Rights CSEC Table II · derivative / convertible security · Conversion / exercise price $4.54 · Expires 2035-03-14 | Direct | 55,682 |
Reported balance
Holding disclosure · report date 2026-06-16 · row 21
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 21 · Balance 55,682 F23: The SARs vest in two equal annual installments on March 15 of 2027 and 2028. F25: This SAR was previously reported as a SAR relating to 37,879 shares of the Issuer's common stock at a base price of $6.66 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3. |
| Share Appreciation Rights CSEC Table II · derivative / convertible security · Conversion / exercise price $5.29 · Expires 2036-03-13 | Direct | 49,297 |
Reported balance
Holding disclosure · report date 2026-06-16 · row 23
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 23 · Balance 49,297 F26: The Share Appreciation Rights vest in three equal annual installments on March 15 of 2027, 2028 and 2029. F28: This SAR was previously reported as a SAR relating to 33,536 shares of the Issuer's common stock at a base price of $7.77 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3. |
Filing footnotes · ownership attribution and instrument terms
F1: On May 21, 2026, the Issuer announced that an authorized committee of the Issuer's board of directors declared a special dividend on each of its outstanding common shares payable on June 16, 2026 to all holders of record as of 5:00 p.m., New York City time, on June 1, 2026 consisting of a special dividend of 0.10 shares of newly issued 9.0% Fixed Rate Cumulative Perpetual Redeemable Series A Preferred Shares (the "Preferred Shares"), having an initial liquidation price of $25 per Preferred Share (the "Dividend"). As a result of the Dividend, the reporting person directly received 4,918 Preferred Shares.
F2: As a result of the Dividend, the reporting person directly received 140 Preferred Shares in his IRA account.
F3: Each Restricted Share Unit P ("RSU") represents a right to receive one share of the Issuer's Series A Preference Shares at settlement.
F4: The RSUs vest in full on March 15, 2027.
F5: The derivative security is fully vested.
F6: This share appreciation right award ("SAR") was previously reported as a SAR relating to 10,609 shares of the Issuer's common stock at a base price of $18.63 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3.
F7: This SAR was previously reported as a SAR relating to 21,218 shares of the Issuer's common stock at a base price of $18.24 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3.
F8: This SAR was previously reported as a SAR relating to 10,383 shares of the Issuer's common stock at a base price of $19.91 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3.
F9: This SAR was previously reported as a SAR relating to 20,766 shares of the Issuer's common stock at a base price of $20.03 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3.
F10: This SAR was previously reported as a SAR relating to 18,678 shares of the Issuer's common stock at a base price of $10.42 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3.
F11: This SAR was previously reported as a SAR relating to 37,356 shares of the Issuer's common stock at a base price of $10.48 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3.
F12: This SAR was previously reported as a SAR relating to 33,333 shares of the Issuer's common stock at a base price of $14.00 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3.
F13: This SAR was previously reported as a SAR relating to 66,667 shares of the Issuer's common stock at a base price of $14.10 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3.
F14: This SAR was previously reported as a SAR relating to 16,573 shares of the Issuer's common stock at a base price of $14.00 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3.
F15: This SAR was previously reported as a SAR relating to 33,146 shares of the Issuer's common stock at a base price of $14.10 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3.
F16: This SAR was previously reported as a SAR relating to 25,445 shares of the Issuer's common stock at a base price of $9.69 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3.
F17: This SAR was previously reported as a SAR relating to 50,890 shares of the Issuer's common stock at a base price of $9.63 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3.
F18: This SAR was previously reported as a SAR relating to 16,522 shares of the Issuer's common stock at a base price of $7.81 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3.
F19: This SAR was previously reported as a SAR relating to 33,044 shares of the Issuer's common stock at a base price of $7.78 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3.
F20: The SARs vest in full on March 15 2027.
F21: This SAR was previously reported as a SAR relating to 20,492 shares of the Issuer's common stock at a base price of $6.16 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3.
F22: This SAR was previously reported as a SAR relating to 40,984 shares of the Issuer's common stock at a base price of $6.22 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3.
F23: The SARs vest in two equal annual installments on March 15 of 2027 and 2028.
F24: This SAR was previously reported as a SAR relating to 18,939 shares of the Issuer's common stock at a base price of $6.69 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3.
F25: This SAR was previously reported as a SAR relating to 37,879 shares of the Issuer's common stock at a base price of $6.66 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3.
F26: The Share Appreciation Rights vest in three equal annual installments on March 15 of 2027, 2028 and 2029.
F27: This SAR was previously reported as a SAR relating to 16,768 shares of the Issuer's common stock at a base price of $7.58 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3.
F28: This SAR was previously reported as a SAR relating to 33,536 shares of the Issuer's common stock at a base price of $7.77 and was adjusted as a result of the Dividend. In connection with the Dividend, all SARs held by the reporting person with respect to the Issuer's common stock were adjusted pursuant to the anti-dilution provisions of the incentive plan under which such award was granted, such that the number of shares subject to, and the base price of, such SAR were adjusted. These adjustments were approved by the compensation committee of the Issuer's board of directors pursuant to Rule 16b-3.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 01, 2019 Filed Apr 3, 2019 21:49 UTC | Liberty Latin America Ltd. LILA · Entity 4630 | Tax withholdingClass C Common Shares | 313 | $20.03 | $6,269.39 |
DisclosureSEC source: 0001712184-19-000122 · wf-form4_155432815842654.xml · nonDerivative · entry 4 ZOOK BRIAN D · CIK 0001725076 · MD, CHIEF ACCOUNTING OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,887 Read SEC document |
| April 01, 2019 Filed Apr 3, 2019 21:49 UTC | Liberty Latin America Ltd. LILA · Entity 4630 | Exercise / conversionClass C Common Shares | 1,078 | $0.00 | $0.00 |
DisclosureSEC source: 0001712184-19-000122 · wf-form4_155432815842654.xml · nonDerivative · entry 3 ZOOK BRIAN D · CIK 0001725076 · MD, CHIEF ACCOUNTING OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,200 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 01, 2019 Filed Apr 3, 2019 21:49 UTC | Liberty Latin America Ltd. LILA · Entity 4630 | Tax withholdingClass A Common Shares | 157 | $19.91 | $3,125.87 |
DisclosureSEC source: 0001712184-19-000122 · wf-form4_155432815842654.xml · nonDerivative · entry 2 ZOOK BRIAN D · CIK 0001725076 · MD, CHIEF ACCOUNTING OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 786 Read SEC document |
| April 01, 2019 Filed Apr 3, 2019 21:49 UTC | Liberty Latin America Ltd. LILA · Entity 4630 | Exercise / conversionClass A Common Shares | 539 | $0.00 | $0.00 |
DisclosureSEC source: 0001712184-19-000122 · wf-form4_155432815842654.xml · nonDerivative · entry 1 ZOOK BRIAN D · CIK 0001725076 · MD, CHIEF ACCOUNTING OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 943 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 20, 2019 Filed Apr 3, 2019 21:49 UTC | Liberty Latin America Ltd. LILA · Entity 4630 | GrantRestricted Share Units C · Derivative | 2,156 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001712184-19-000122 · wf-form4_155432815842654.xml · derivative · entry 9 ZOOK BRIAN D · CIK 0001725076 · MD, CHIEF ACCOUNTING OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,156 Underlying: Class C Common Shares · 2,156 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Share Unit represents a right to receive one share of the Issuer's Class A common shares or Class C common shares, as the case may be, at settlement. F1 · price: Each Restricted Share Unit represents a right to receive one share of the Issuer's Class A common shares or Class C common shares, as the case may be, at settlement. F2 · derivative.exercise_date: The Restricted Share Units vest in two equal semi-annual installments on April 1, 2019 and October 1, 2019. F2 · derivative.expiration_date: The Restricted Share Units vest in two equal semi-annual installments on April 1, 2019 and October 1, 2019. Read SEC document |
| March 20, 2019 Filed Apr 3, 2019 21:49 UTC | Liberty Latin America Ltd. LILA · Entity 4630 | GrantRestricted Share Units A · Derivative | 1,078 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001712184-19-000122 · wf-form4_155432815842654.xml · derivative · entry 8 ZOOK BRIAN D · CIK 0001725076 · MD, CHIEF ACCOUNTING OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,078 Underlying: Class A Common Shares · 1,078 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Share Unit represents a right to receive one share of the Issuer's Class A common shares or Class C common shares, as the case may be, at settlement. F1 · price: Each Restricted Share Unit represents a right to receive one share of the Issuer's Class A common shares or Class C common shares, as the case may be, at settlement. F2 · derivative.exercise_date: The Restricted Share Units vest in two equal semi-annual installments on April 1, 2019 and October 1, 2019. F2 · derivative.expiration_date: The Restricted Share Units vest in two equal semi-annual installments on April 1, 2019 and October 1, 2019. Read SEC document |
| May 01, 2018 Filed May 3, 2018 21:49 UTC | Liberty Latin America Ltd. LILA · Entity 4630 | GrantShare Appreciation Rights C · Derivative | 21,218 | $0.00 Strike: $18.24 | $0.00 |
DisclosureSEC source: 0001712184-18-000153 · wf-form4_152538415011849.xml · derivative · entry 2 ZOOK BRIAN D · CIK 0001725076 · MD, CHIEF ACCOUNTING OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,218 Underlying: Class C Common Shares · 21,218 shares Expires 2025-05-01 F1 · derivative.exercise_date: The SARs provide for vesting of 12.5% of the shares on November 1, 2018, and the remaining shares in 14 equal quarterly installments commencing on February 1, 2019. Read SEC document |
| May 01, 2018 Filed May 3, 2018 21:49 UTC | Liberty Latin America Ltd. LILA · Entity 4630 | GrantShare Appreciation Rights A · Derivative | 10,609 | $0.00 Strike: $18.63 | $0.00 |
DisclosureSEC source: 0001712184-18-000153 · wf-form4_152538415011849.xml · derivative · entry 1 ZOOK BRIAN D · CIK 0001725076 · MD, CHIEF ACCOUNTING OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,609 Underlying: Class A Common Shares · 10,609 shares Expires 2025-05-01 F1 · derivative.exercise_date: The SARs provide for vesting of 12.5% of the shares on November 1, 2018, and the remaining shares in 14 equal quarterly installments commencing on February 1, 2019. Read SEC document |
| December 29, 2017 Filed Feb 15, 2018 02:19 UTC | Liberty Latin America Ltd. LILA · Entity 4630 | OtherShare Appreciation Rights C · Derivative | 5,304 | $0.00 Strike: $25.60 | $0.00 |
DisclosureSEC source: 0001712184-18-000104 · wf-form5_151866114479648.xml · derivative · entry 6 ZOOK BRIAN D · CIK 0001725076 · MD, CHIEF ACCOUNTING OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,304 Underlying: Class C Common Shares · 5,304 shares Expires 2024-08-01 F2 · kind: This share appreciation right ("SAR") was granted as a result of the adjustments described in this footnote. In connection with the completion of the Split-Off, all SARs awards held by the reporting person with respect to Liberty Global's LiLAC ordinary shares (each, a "Pre-Split LiLAC Award") were adjusted pursuant to the anti-dilution provisions of the incentive plan under which the SAR awards were granted, such that the reporting person (i) disposed of the Pre-Split LiLAC Award and (ii) received a SAR relating to shares of the corresponding class of the Issuer's common shares ("Post-Split Splitco Award"). The terms of the Post-Split Splitco Award will, in all material respects, be the same as those of the corresponding Pre-Split LiLAC Award. These adjustments were approved by the Issuer's board of directors pursuant to Rule 16b-3 under the Act. F3 · derivative.exercise_date: The SARs provide for vesting of 12.5% of the shares on February 1, 2018, and the remaining shares in 14 equal quarterly installments commencing on May 1, 2018. Read SEC document |
| December 29, 2017 Filed Feb 15, 2018 02:19 UTC | Liberty Latin America Ltd. LILA · Entity 4630 | OtherShare Appreciation Rights A · Derivative | 2,652 | $0.00 Strike: $25.82 | $0.00 |
DisclosureSEC source: 0001712184-18-000104 · wf-form5_151866114479648.xml · derivative · entry 5 ZOOK BRIAN D · CIK 0001725076 · MD, CHIEF ACCOUNTING OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,652 Underlying: Class A Common Shares · 2,652 shares Expires 2024-08-01 F2 · kind: This share appreciation right ("SAR") was granted as a result of the adjustments described in this footnote. In connection with the completion of the Split-Off, all SARs awards held by the reporting person with respect to Liberty Global's LiLAC ordinary shares (each, a "Pre-Split LiLAC Award") were adjusted pursuant to the anti-dilution provisions of the incentive plan under which the SAR awards were granted, such that the reporting person (i) disposed of the Pre-Split LiLAC Award and (ii) received a SAR relating to shares of the corresponding class of the Issuer's common shares ("Post-Split Splitco Award"). The terms of the Post-Split Splitco Award will, in all material respects, be the same as those of the corresponding Pre-Split LiLAC Award. These adjustments were approved by the Issuer's board of directors pursuant to Rule 16b-3 under the Act. F3 · derivative.exercise_date: The SARs provide for vesting of 12.5% of the shares on February 1, 2018, and the remaining shares in 14 equal quarterly installments commencing on May 1, 2018. Read SEC document |
| December 29, 2017 Filed Feb 15, 2018 02:19 UTC | Liberty Latin America Ltd. LILA · Entity 4630 | OtherClass C Common Shares | 1,312 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001712184-18-000104 · wf-form5_151866114479648.xml · nonDerivative · entry 4 ZOOK BRIAN D · CIK 0001725076 · MD, CHIEF ACCOUNTING OFFICER 10b5-1 filing: Not disclosed Ownership: Indirect · By 401(k) Plan Disclosed balance after: 1,312 F1 · kind: Pursuant to the Split-Off (as described in the Remarks section), the reporting person received one share of the same class of common shares of Liberty Latin America Ltd. (the "Issuer") for each share of Liberty Global plc's ("Liberty Global") LiLAC ordinary shares held by the reporting person at 5:00 p.m., New York City time, on December 29, 2017. The Split-Off was exempt pursuant to Rule 16b-7 under the Securities Exchange Act of 1934, as amended (the "Act"). F1 · price: Pursuant to the Split-Off (as described in the Remarks section), the reporting person received one share of the same class of common shares of Liberty Latin America Ltd. (the "Issuer") for each share of Liberty Global plc's ("Liberty Global") LiLAC ordinary shares held by the reporting person at 5:00 p.m., New York City time, on December 29, 2017. The Split-Off was exempt pursuant to Rule 16b-7 under the Securities Exchange Act of 1934, as amended (the "Act"). Read SEC document |
| December 29, 2017 Filed Feb 15, 2018 02:19 UTC | Liberty Latin America Ltd. LILA · Entity 4630 | OtherClass C Common Shares | 1,122 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001712184-18-000104 · wf-form5_151866114479648.xml · nonDerivative · entry 3 ZOOK BRIAN D · CIK 0001725076 · MD, CHIEF ACCOUNTING OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,122 F1 · kind: Pursuant to the Split-Off (as described in the Remarks section), the reporting person received one share of the same class of common shares of Liberty Latin America Ltd. (the "Issuer") for each share of Liberty Global plc's ("Liberty Global") LiLAC ordinary shares held by the reporting person at 5:00 p.m., New York City time, on December 29, 2017. The Split-Off was exempt pursuant to Rule 16b-7 under the Securities Exchange Act of 1934, as amended (the "Act"). F1 · price: Pursuant to the Split-Off (as described in the Remarks section), the reporting person received one share of the same class of common shares of Liberty Latin America Ltd. (the "Issuer") for each share of Liberty Global plc's ("Liberty Global") LiLAC ordinary shares held by the reporting person at 5:00 p.m., New York City time, on December 29, 2017. The Split-Off was exempt pursuant to Rule 16b-7 under the Securities Exchange Act of 1934, as amended (the "Act"). Read SEC document |
| December 29, 2017 Filed Feb 15, 2018 02:19 UTC | Liberty Latin America Ltd. LILA · Entity 4630 | OtherClass A Common Shares | 93 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001712184-18-000104 · wf-form5_151866114479648.xml · nonDerivative · entry 2 ZOOK BRIAN D · CIK 0001725076 · MD, CHIEF ACCOUNTING OFFICER 10b5-1 filing: Not disclosed Ownership: Indirect · By 401(k) Plan Disclosed balance after: 93 F1 · kind: Pursuant to the Split-Off (as described in the Remarks section), the reporting person received one share of the same class of common shares of Liberty Latin America Ltd. (the "Issuer") for each share of Liberty Global plc's ("Liberty Global") LiLAC ordinary shares held by the reporting person at 5:00 p.m., New York City time, on December 29, 2017. The Split-Off was exempt pursuant to Rule 16b-7 under the Securities Exchange Act of 1934, as amended (the "Act"). F1 · price: Pursuant to the Split-Off (as described in the Remarks section), the reporting person received one share of the same class of common shares of Liberty Latin America Ltd. (the "Issuer") for each share of Liberty Global plc's ("Liberty Global") LiLAC ordinary shares held by the reporting person at 5:00 p.m., New York City time, on December 29, 2017. The Split-Off was exempt pursuant to Rule 16b-7 under the Securities Exchange Act of 1934, as amended (the "Act"). Read SEC document |
| December 29, 2017 Filed Feb 15, 2018 02:19 UTC | Liberty Latin America Ltd. LILA · Entity 4630 | OtherClass A Common Shares | 404 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001712184-18-000104 · wf-form5_151866114479648.xml · nonDerivative · entry 1 ZOOK BRIAN D · CIK 0001725076 · MD, CHIEF ACCOUNTING OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 404 F1 · kind: Pursuant to the Split-Off (as described in the Remarks section), the reporting person received one share of the same class of common shares of Liberty Latin America Ltd. (the "Issuer") for each share of Liberty Global plc's ("Liberty Global") LiLAC ordinary shares held by the reporting person at 5:00 p.m., New York City time, on December 29, 2017. The Split-Off was exempt pursuant to Rule 16b-7 under the Securities Exchange Act of 1934, as amended (the "Act"). F1 · price: Pursuant to the Split-Off (as described in the Remarks section), the reporting person received one share of the same class of common shares of Liberty Latin America Ltd. (the "Issuer") for each share of Liberty Global plc's ("Liberty Global") LiLAC ordinary shares held by the reporting person at 5:00 p.m., New York City time, on December 29, 2017. The Split-Off was exempt pursuant to Rule 16b-7 under the Securities Exchange Act of 1934, as amended (the "Act"). Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.